#ARCHBR - Twitter Hashtag

over 3 years ago

Validación de los criterios ARC-HBR para pacientes con enfermedad vascular periférica, por el Dr. @CMGarmendia 🔗 Léalo https://t.co/IH5DrEFqg2 #Intervencionismo #Cardiología #EnfermedadVascular #Femoral #Poplíteo #ARCHBR #Bleeding #PVD #EVP #InterventionalCardiology #Health

CACIarg's tweet photo. Validación de los criterios ARC-HBR para pacientes con enfermedad vascular periférica, por el Dr. @CMGarmendia

🔗 Léalo https://t.co/IH5DrEFqg2

#Intervencionismo #Cardiología #EnfermedadVascular #Femoral #Poplíteo #ARCHBR #Bleeding #PVD #EVP #InterventionalCardiology #Health https://t.co/uLN1GPy1kv

0

4

1

0

266

Felice Gragnano @FeliceGragnano

about 4 years ago

Bleeding risk in ACS patients #ARCHBR @EuroInterventio @vlgmrc

EuroIntervention

@EuroInterventio

about 4 years ago

Focus on BLEEDING RISK. Read more in our #EIJBestOf article by Gragnano F on clinical presentation and bleeding risk after PCI. #EAPCI #bleedingrisk #ARC-HBR https://t.co/KE5vDw2qjv

EuroInterventio's tweet photo. Focus on BLEEDING RISK. Read more in our #EIJBestOf article by Gragnano F on clinical presentation and bleeding risk after PCI. #EAPCI #bleedingrisk #ARC-HBR https://t.co/KE5vDw2qjv https://t.co/pqp4hDf6zG

0

38

13

4

0

10

1

0

Claudio Montalto @MdMontalto

over 4 years ago

In this meta-analysis 📚 we summarized evidence for the use of #ARCHBR in pt undergoing #PCI Also find our take for future development of the criteria Read and share: open access on the HJC: https://t.co/HwgC8Qdvui w/@Costa_F_8 @andrea_muna @l_arzuffi @Ale_MM1988

0

4

3

0

Claudio Montalto @MdMontalto

about 5 years ago

Insights from TICO: ticagrelor alone to reduce #bleeding in selected subgroups. Age >65 is not an #ARCHBR criteria.. will this strategy be useful in older adults at HBR? Another great #ESCAbstract on the #ESCCongress Research Gateway https://t.co/gYDykYegpg via @escardio

MdMontalto's tweet photo. Insights from TICO: ticagrelor alone to reduce #bleeding in selected subgroups. Age >65 is not an #ARCHBR criteria.. will this strategy be useful in older adults at HBR?

Another great #ESCAbstract on the #ESCCongress Research Gateway https://t.co/gYDykYegpg
via @escardio https://t.co/xmTAHTPQ6y

0

2

0

Claudio Montalto @MdMontalto

about 5 years ago

From #ESCCongress Commitee selection: in this #ESCAbstract our group focused on the prevalence and utility of #ARCHBR in the real-world. Is there ground for a simpler, user-friendly definition? w Sergio Leonardi @unipv https://t.co/rvvOu0UMVI via @escardio @ESCardioNews

0

8

1

0

Radcliffe Cardiology

@radcliffeCARDIO

about 5 years ago

🩸 Bleeding matters! Up to 40% of the PCI population are HBR patients. Identify and manage your HBR patient. #DES, #DAPT, #PCI, #ARCHBR Find out more! 👉 https://t.co/HEaaTspurW

0

3

0

Radcliffe Cardiology

@radcliffeCARDIO

over 5 years ago

It is of major importance to identify High Bleeding Risk patients. To treat these HBR patients, consider Resolute Onyx™. Resolute Onyx™ DES is safe and effective in HBR patients at 1-mo DAPT. Find out more! https://t.co/zWiXQwRvHy #Onyxone, #DES, #DAPT, #PCI, #ARCHBR

0

4

0

Vanessa Blumer, MD, FACC, FHFSA @vbluml

almost 6 years ago

@DFCapodanno defining PCI patients at "high-bleeding risk" @CVCTForum #CVCT2020 #ARCHBR @FaiezZANNAD @drdargaray @lucreciamburgos @ersied727 @DrRajivsankar @SantosGallegoMD @rachkataria @KevinShahMD @paomorejon @AlexNowbar

vbluml's tweet photo. @DFCapodanno defining PCI patients at "high-bleeding risk" @CVCTForum #CVCT2020
#ARCHBR

@FaiezZANNAD @drdargaray @lucreciamburgos @ersied727 @DrRajivsankar @SantosGallegoMD @rachkataria @KevinShahMD @paomorejon @AlexNowbar https://t.co/GZKCLW1ReR

0

6

4

1

0

Davide Capodanno

@DFCapodanno

almost 7 years ago

#ARCHBR Part 2, work in progress. Thanks to all participants for bringing their expertise and contributing so actively. (Title of the group photo: “It could be worse: for example, it could rain”)